资讯

Take steps towards a healthier lifestyle with the Venu 4 from Garmin

Garmin (NYSE: GRMN) today announced Venu® 4, the latest smartwatch in the award-winning Venu lineup with innovative new ...

BIMZELX® (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed ...

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).